Health effects of oleic acid and long chain omega-3 fatty acids (EPA and DHA) enriched milks. A review of intervention studies

Pharmacological Research

Volumn 61, Issue 3, 2010, Pages 200-207

  Lopez Huertas, Eduardo ^a  

^a CSIC   (Spain)

Author keywords

Cardiovascular disease; Cholesterol; Docosahexaenoid acid (DHA); Eicosapentaenoic acid (EPA); Enriched milk; Functional foods; Oleic acid; Review

Indexed keywords

DOCOSAHEXAENOIC ACID; FISH OIL; ICOSAPENTAENOIC ACID; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OLEIC ACID; OMEGA 3 FATTY ACID; POLYUNSATURATED FATTY ACID; TRIACYLGLYCEROL; VEGETABLE OIL; VITAMIN;

BIOAVAILABILITY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR EFFECT; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; DIET SUPPLEMENTATION; DIETARY INTAKE; FOOD INTAKE; FOOD SAFETY; HUMAN; INTERVENTION STUDY; LIPID BLOOD LEVEL; MILK; NUTRITIONAL HEALTH; NUTRITIONAL SUPPORT; PRIORITY JOURNAL; REVIEW; RISK FACTOR; RISK REDUCTION; THERAPY EFFECT; TRIACYLGLYCEROL BLOOD LEVEL; ANIMAL; CLINICAL TRIAL (TOPIC); PROCEDURES;

ANIMALS; CLINICAL TRIALS AS TOPIC; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; FATTY ACIDS, OMEGA-3; FOOD, FORTIFIED; HUMANS; MILK; OLEIC ACID;

EID: 77649269847     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2009.10.007     Document Type: Review

References (50)

1. American Heart Association (AHA) Scientific Statement 2006. Diet and lifestyle recommendations revision: a scientific statement from the American Heart Association Nutrition Committee. Circulation 114 (2006) 82-96
2. The World Health Organisation. Diet nutrition and the prevention of chronic diseases. Report of the WHO/FAO Joint Expert Consultation, WHO, Technical Report Series 916; 2003.
3. Kris-Etherton P.M. Monounsaturated fatty acids and risk of cardiovascular disease. Circulation 100 (1999) 1253-1258
4. Wahrburg U. What are the health effects of fat?. Eur J Nutr 43 (2004) 1/6-1/11
5. Dietary Guidelines Advisory Committee of the US. Fats. US Department of Health and Human Services, The Report of the Dietary Guidelines Advisory Committee on Dietary Guidelines for Americans, http://www.health.gov/dietaryguidelines/dga2005/report/HTML/D4_Fats.htm; 2005.
6. Vessby B., Unsitupa M., Hermansen K., Riccardi G., Rivellese A.A., Tapsell L.C., et al. Substituting dietary saturated for monounsaturated fat impairs insulin sensitivity in healthy men and women: the KANWU Study. Diabetologia 44 (2001) 312-319
7. Hulshof K.F.A.M., van Erp-Baart M.A., Anttolainen M., Becker W., Church S.M., Couet C., et al. Intake of fatty acids in Western Europe with emphasis on trans fatty acids: the TRANSFAIR study. Eur J Clin Nutr 53 (1999) 143-157
8. Report of the British Nutrition Foundation's Task Force: n - 3 fatty acids and health. The British Nutrition Foundation. New York/London: Chapman & Hall; 1999.
9. Hooper L, Thompson RL, Harrison RA, Summerbell CD, Moore H, Worthington HV, et al. Omega 3 fatty acids for prevention and treatment of cardiovascular disease (Cochrane Review). In: The Cochrane Library, Issue 2, Oxford; 2005.
10. Calder P.C. n - 3 Fatty acids and cardiovascular disease: evidence explained and mechanisms explored. Clin Sci (Lond) 107 (2004) 1-11
11. Kris-Etherton P.M., Harris W.S., Appel L.J., and American Heart Association. Nutrition Committee. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 106 (2002) 2747-2757
12. EFSA. Opinion of the scientific panel on dietetic products, nutrition and allergies on a request from the Commission related to labelling reference intake values for n - 3 and n - 6 polyunsaturated fatty acids. EFSA J 1176 (2009) 1-11
13. Kris-Etherton P.M., Taylor D.S., Yu-Poth S., Huth P., Moriarty K., Fishell V., et al. Polyunsaturated fatty acids in the food chain in the United States. Am J Clin Nutr 71 1 Suppl. (2000) 179S-188S
14. EFSA. 2005. Opinion of the Scientific Panel on Dietetic Products, Nutrition and Allergies on a request from the Commission related to nutrition claims concerning omega-3 fatty acids, monounsaturated fat, polyunsaturated fat and unsaturated fat. EFSA J 2005; 253, 1-29. http://www.efsa.eu.int/science/nda/nda_opinions/catindex_en.html.
15. Arterburn L.M., Hall E.B., and Oken H. Distribution, interconversion, and dose response of n - 3 fatty acids in humans. Am J Clin Nutr 83 6 Suppl. (2006) 1467S-1476S
16. Pawlosky R.J., Hibbeln J.R., Novotny J.A., and Salem Jr. N. Physiological compartmental analysis of alpha-linolenic acid metabolism in adult humans. J Lipid Res 42 (2001) 1257-1265
17. Kris-Etherton P.M., Harris W.S., Appel L.J., AHA Nutrition Committee, and American Heart Association. Omega-3 fatty acids and cardiovascular disease: new recommendations from the American Heart Association. Arterioscler Thromb Vasc Biol 23 (2003) 151-152
18. Baldwin N and Rice R on behalf of the Joint Health Claims Initiative expert committee on Omega 3, http://www.jhci.org.uk/approv/omega.htm; 2004.
19. Agence Français de Sécurité Sanitaire des Aliments (AFFSA). The omega-3 fatty acids and the cardiovascular system: nutritional benefits and claims (2003). http://www.afssa.fr/ftp/afssa/basedoc/rapportomega3.pdf
20. Health Council of the Netherlands. Guidelines for a healthy diet 2006. The Hauge: Health Council of the Netherlands Publication No. 2006/21E, http://www.gr.nl/pdf.php?ID=1481&p=1.
21. Estévez-González M.D., Saavedra-Santana P., and Betancor-León P. Reduction of serum cholesterol and low-density lipoprotein cholesterol levels in a juvenile population after isocaloric substitution of whole milk with a milk preparation (skimmed milk enriched with oleic acid). J Pediatr 132 (1998) 85-89
22. Visioli F., Rise P., Plasmati E., Pazzucconi F., Sirtori C., and Galli C. Very low intakes of n - 3 fatty acids incorporated into bovine milk reduce plasma triacylglycerols and increase HDL-cholesterol concentrations in healthy subjects. Pharmacol Res 41 (2000) 571-576
23. Baró L., Fonollá J., Peña J.L., Martinez-Ferez A., Lucena A., Jiménez J., et al. n - 3 fatty acids plus oleic acid supplemented milk reduces total and LDL cholesterol, homocysteine and levels of endothelial adhesion molecules in healthy humans. Clin Nutr 22 (2003) 175-182
24. Carrero J.J., Baró L., Fonollá J., González-Santiago M., Martínez-Férez A., Castillo R., et al. Cardiovascular effects of milk enriched with n - 3 polyunsaturated fatty acids, oleic acid folic acid and vitamins E, B6 and B12 in volunteers with mild hyperlipidaemia. Nutrition 29 (2004) 521-527
25. Cobiac L., Clifton P.M., Abbey M., Belling G.B., and Nestel P.J. Lipid, lipoprotein, and hemostatic effects of fish vs fish-oil n - 3 fatty acids in mildly hyperlipidemic males. Am J Clin Nutr 53 (1991) 1210-1216
26. Harris W.S. n - 3 fatty acids and serum lipoproteins: human studies. Am J Clin Nutr 65 5 Suppl. (1997) 1645S-1654S
27. Fonollá J., López-Huertas E., Machado F.J., Molina D., Alvarez I., Mármol E., et al. Milk enriched with "healthy fatty acids" improves cardiovascular risk markers and nutritional status in human volunteers. Nutrition 25 (2009) 408-414
28. Castro I.A., Monteiro V.C.B., Barroso L.P., and Bertolami M.C. Effect of eicosapentaenoic/docosahexaenoic fatty acids and soluble fibers on blood lipids of individuals classified into different levels of lipidemia. Nutrition 23 (2007) 127-137
29. Carrero J.J., López-Huertas E., Salmerón L.M., Baró L., and Ros E. Daily supplementation with (n - 3) PUFAs, oleic acid, folic acid, and vitamins B-6 and E increases pain-free walking distance and improves risk factors in men with peripheral vascular disease. J Nutr 135 (2005) 1393-1399
30. Carrero J.J., Fonollá J., Marti J.L., Jiménez J., Boza J.J., and López-Huertas E. Intake of fish oil, oleic acid, folic acid, and vitamins B-6 and E for 1 year decreases plasma C-reactive protein and reduces coronary heart disease risk factors in male patients in a cardiac rehabilitation program. J Nutr 137 (2007) 384-390
31. Benito P., Caballero J., Moreno J., Gutiérrez-Alcántara C., Muñoz C., and Rojo G. Effects of milk enriched with omega-3 fatty acid, oleic acid and folic acid in patients with metabolic syndrome. Clin Nutr 25 (2006) 581-587
32. Varela G., Moreiras O., Carbajal A., Perea I., Varela-Moreiras G., Ruiz-Roso B., et al. Estudio Nacional de Nutrición y Alimentación 1991, Tomo I. (National Study of Food Intake and Nutrition, vol. 1) (1995), Instituto Nacional de Estadística, Madrid, Spain
33. Subar A.F., Krebs-Smith S.M., Cook A., and Kahle L.L. Dietary sources of nutrients among US adults, 1989 to 1991. J Am Diet Assoc 98 (1998) 537-547
34. Henderson L., Gregory J., Irving K., Bates C.J., Prentice A., Perks J., et al. The National Diet and Nutrition Survey: adults aged 19-64 years, vol. 3. Vitamin and mineral intake and urinary analytes (2003), Her Majesty's Stationery Office, London, United Kingdom
35. Garaiova I., Guschina I.A., Plummer S.F., Tang J., Wang D., and Plummer N.T. A randomised cross-over trial in healthy adults indicating improved absorption of omega-3 fatty acids by pre-emulsification. Nutr J 6 (2007) 4
36. Grundy S.M., and Denke M.A. Dietary influences on serum lipids and lipoproteins. J Lipid Res 31 (1990) 1149-1172
37. Kris-Etherton P.M., and Yu S. Individual fatty acid effects on plasma lipids and lipoproteins: human studies. Am J Clin Nutr 65 Suppl 5 (1997) 1628S-1644S
38. Mensink R.P., and Katan M.B. Effects of dietary fatty acids on serum lipids and lipoproteins: a meta-analysis of 27 trials. Arterioscler Thromb 12 (1992) 911-919
39. Keys A., Arvanis C., and Blackburn H. Seven countries: a multivariate analysis of death and coronary heart disease (1980), Harvard University Press, Cambridge, MA p. 381
40. Keys A., Menotti A., Aravanis C., Blackburn H., Djordjevic B.S., Buzina R., et al. The Seven Countries Study: 2,289 deaths in 15 years. Prev Med 13 (1984) 141-154
41. Law M.R., Wald N.J., and Thompson S.G. By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease?. BMJ 308 (1994) 367-372
42. Law M.R. Lowering heart disease risk with cholesterol reduction: evidence from observational studies and clinical trials. Eur Heart J Suppl (1999) S3-S8
43. Gorjão R., Azevedo-Martins A.K., Rodrigues H.G., Abdulkader F., Arcisio-Miranda M., Procopio J., et al. Comparative effects of DHA and EPA on cell function. Pharmacol Ther 122 1 (2009) 56-64
44. Mori T.A., Burke V., Puddey I.B., Watts G.F., O'Neal D.N., Best J.D., et al. Purified eicosapentaenoic and docosahexaenoic acids have differential effects on serum lipids and lipoproteins. LDL particle size, glucose, and insulin in mildly hyperlipidemic men. Am J Clin Nutr 71 5 (2000) 1085-1094
45. Buckley R., Shewring B., Turner R., Yaqoob P., and Minihane A.M. Circulating triacylglycerol and apoE levels in response to EPA and docosahexaenoic acid supplementation in adult human subjects. Br J Nutr 92 (2004) 477-483
46. Finley D.A., Lönnerdal B., Dewey K.G., and Grivetti L.E. Breast milk composition: fat content and fatty acid composition in vegetarians and non-vegetarians. Am J Clin Nutr. 41 (1985) 787-800
47. Heird W.C., and Lapillonne A. The role of essential fatty acids in development. Annu Rev Nutr 25 (2005) 549-571
48. Richardson A.J., and Montgomery P. The Oxford-Durham study: a randomized, controlled trial of dietary supplementation with fatty acids in children with developmental coordination disorder. Pediatrics 115 (2005) 1360-1366
49. Osendarp S.J., Baghurst K.I., Bryan J., Calvaresi E., Hughes D., Hussaini M., et al. Effect of a 12-mo micronutrient intervention on learning and memory in well-nourished and marginally nourished school-aged children: 2 parallel, randomized, placebo-controlled studies in Australia and Indonesia. Am J Clin Nutr 86 (2007) 1082-1093
50. Third Report of the National Cholesterol Education Program Expert Panel. Detection, evaluation and treatment of high blood cholesterol in adults (ATP III). National.